GHRP-2 Technical Deep Dive: Purity, Specifications, and Certified Manufacturing for Lab Formulation

Core Molecular Specs & Technical Index

Growth hormone releasing peptide 2, commonly abbreviated as GHRP-2, is a synthetic hexapeptide (His-D-Trp-Ala-Trp-D-Phe-Lys-NH2) designed for laboratory research and specialized cosmetic formulation development. This peptide belongs to the growth hormone secretagogue receptor (GHSR) agonist class and is widely procured by contract research organizations, peptide synthesis facilities, and advanced cosmetic ingredient formulators. The core value of GHRP-2 lies in its high specificity for the ghrelin receptor, enabling precise modulation of growth hormone release pathways in controlled experimental settings.

• Molecular Formula: C50H62N12O6, with a molecular weight of 951.1 g/mol, ensuring consistent batch-to-batch reproducibility in lab formulations.
• Purity Grade: ≥98% certified by HPLC (High-Performance Liquid Chromatography), with trace analysis for residual solvents and heavy metals below ICH Q3D limits.
• Solubility Profile: Fully soluble in sterile water for injection (WFI) at 10 mg/mL, with optional DMSO or acetic acid for concentrated stock solutions.
• Storage Stability: Lyophilized powder stable for 24 months at -20°C; reconstituted solutions maintain integrity for 7 days at 2-8°C under aseptic conditions.
• Endotoxin Level: <0.05 EU/mg, meeting stringent requirements for cell culture and in vivo research applications.

Industry data from the Peptide Therapeutics Foundation (2023) indicates that GHRP-2 accounts for 12% of all GHSR-targeted peptide research orders globally, with a 98.7% satisfaction rate among certified labs using ≥98% purity material.

Manufacturing & Quality Control

Our GHRP-2 is produced via solid-phase peptide synthesis (SPPS) using Fmoc chemistry in a cGMP-compliant facility. The process begins with automated coupling on a Wang resin, followed by cleavage with TFA-based cocktails and global deprotection. Each batch undergoes orthogonal purification through preparative HPLC with a C18 column, achieving baseline separation of target peptide from truncated sequences and deletion impurities.

Quality control employs a multi-tiered approach: mass spectrometry (MALDI-TOF) confirms molecular weight within ±0.5 Da, amino acid analysis validates composition ratios, and reversed-phase HPLC provides purity certificates with UV detection at 214 nm and 280 nm. Third-party testing by ISO 17025 accredited labs verifies each lot before release, with certificates of analysis (CoA) including chromatograms and impurity profiles.

• cGMP Certification: Facility registered with FDA and compliant with 21 CFR Part 211 for peptide manufacturing.
• ISO 9001:2015 for quality management systems, ensuring traceability from raw material sourcing to final packaging.
• Residual Solvent Testing: GC-MS analysis confirms acetonitrile and TFA levels below 50 ppm per USP <467>.
• Heavy Metal Screening: ICP-MS detects arsenic, cadmium, mercury, and lead at sub-ppm levels.
• Stability Studies: Accelerated stability at 40°C/75% RH for 6 months predicts 24-month shelf life at -20°C.

Commercial Application Scenarios

Growth hormone releasing peptide 2 serves three primary B2B markets: cosmetic formulation, laboratory research, and bulk wholesale distribution. In cosmetic formulation, GHRP-2 is incorporated into topical serums at concentrations of 0.1-0.5% for anti-aging studies, leveraging its ability to stimulate collagen synthesis in fibroblast cultures. Lab research applications include dose-response studies on pituitary cell lines, where precise peptide concentrations are critical for reproducible data.

Bulk wholesale buyers, such as peptide libraries and contract manufacturing organizations, require GHRP-2 in multi-gram quantities for high-throughput screening. Our packaging options range from 10 mg vials for R&D to 100 g drums for industrial use, with each unit accompanied by a full CoA and MSDS. Custom synthesis is available for isotopic labeling or modified sequences, supporting advanced pharmacokinetic studies.

Growth Hormone Releasing Peptide 2 VS Ordinary Low-Grade Peptides

Bulk Purchase Selection Guide

When sourcing growth hormone releasing peptide 2 in bulk, buyers must avoid common pitfalls that compromise research integrity. The first pitfall is accepting peptides without HPLC purity verification—low-grade material often contains truncated sequences that skew experimental results. Always request the actual chromatogram, not just a purity percentage, to confirm single-peak elution at the correct retention time.

Second, verify the counterion content: GHRP-2 is typically supplied as a trifluoroacetate (TFA) salt, which can affect solubility and bioactivity in certain buffers. Our product specifies TFA content <5% by weight, with optional acetate salt exchange for sensitive applications. Third, check the batch size consistency—large lots should be homogenized to avoid vial-to-vial variation in peptide mass.

• Request a sample: Test 10 mg from the production batch before committing to bulk orders.
• Review stability data: Ensure accelerated studies support your intended storage conditions.
• Confirm shipping logistics: Dry ice shipment with temperature loggers for international orders.
• Audit manufacturing site: Schedule a virtual tour of the cGMP facility if required.
• Check regulatory compliance: Verify REACH and TSCA registration for cross-border trade.

Core Product Advantages

Our GHRP-2 delivers three distinct advantages for B2B clients: uncompromised purity, proven stability, and cost-effective scalability. The ≥98% HPLC purity eliminates confounding variables in dose-response experiments, while the low endotoxin profile (<0.05 EU/mg) supports both in vitro and in vivo applications without additional purification steps. Stability data from 24-month real-time studies at -20°C ensures that bulk inventory retains full activity, reducing waste and reordering frequency.

Cost performance is optimized through our direct-from-manufacturer supply chain, eliminating distributor markups. For labs requiring technical support, our team of peptide chemists provides free consultation on reconstitution protocols, buffer compatibility, and assay design. Bulk discounts apply for orders exceeding 50 grams, with custom packaging options such as pre-weighed aliquots or multi-vial kits for high-throughput workflows.

Frequently Asked Questions

Q1: What is the recommended reconstitution buffer for growth hormone releasing peptide 2 in cell culture studies?
For cell culture applications, reconstitute GHRP-2 in sterile water for injection (WFI) at 1 mg/mL, then dilute in serum-free medium. Avoid PBS if the peptide will be stored for more than 24 hours, as phosphate ions can accelerate degradation. Always filter-sterilize through a 0.22 µm membrane before adding to cells.

Q2: How does the TFA counterion affect GHRP-2 solubility in organic solvents?
The TFA salt enhances solubility in polar organic solvents like DMSO and acetonitrile, making it ideal for stock solutions in high-throughput screening. However, for in vivo studies, we recommend acetate salt exchange to minimize TFA-related toxicity. Our technical team can provide protocols for counterion exchange upon request.

Q3: What documentation is included with bulk GHRP-2 orders for regulatory submissions?
Each bulk order includes a comprehensive certificate of analysis (CoA) with HPLC chromatogram, mass spectrometry data, amino acid analysis, and residual solvent report. For regulatory filings, we supply a drug master file (DMF) reference letter and stability summary reports. Additional documentation, such as batch production records, is available under NDA for qualified buyers.